in cells and affect 1 in every 12,000 people in the United States each year.
Payne and his colleagues have spent the last 36 months perfecting the delivery of the proteins across cell membranes and are ready to begin animal studies on the technology once they receive additional research funding.
"This technology could replace the current gene therapy being used in a much safer way," he said. "And while this study is aimed at preventing deaths in infants, potentially many adults could benefit from this. Over the span of a lifetime, many adults will accumulate defects in the mitochondria, which show up as heart and brain diseases later."
Brenner Children's Hospital is part of Wake Forest University Baptist Medical Center. Colleagues who collaborated with this project include Victoria Del Gaizo, Payne's graduate student, and Jamal Ibdah, M.D., associate professor of gastroenterology at Wake Forest.
Page: 1 2 Related biology news :1
Contact: Rae Beasley
Wake Forest University Baptist Medical Center
. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting2
. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients3
. Novel approaches to current cellular therapies continue progress toward disease prevention4
. Novel therapies show promise against myeloid leukemia5
. Novel sensors help clear the air6
. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs7
. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis8
. Novel therapeutic target identified in fight against Rheumatoid Arthritis9
. Novel bacterium detoxifies chlorinated pollutants10
. Novel flu vaccine shows promise in mice11
. Novel method identifies hidden genes